Pro Medicus is under Algo Engine buy conditions.
PME announced a $25m seven year deal with NYU Langone Healthcare, which has now followed the recent $22m 5 year deal with Northwestern Memorial Healthcare.
These deals provide further evidence of Pro Medicus’ acceptance among some of the largest hospital groups in the US.
The stock is expensive, but the growth story continues to look compelling.
Technically, we have seen a recent higher low with strong buying off the $24.50 level in Friday’s session.